Abnormal hemoglobin H band in myelodysplastic syndromes (MDS): A case report

被引:2
作者
Liu, Cong [1 ]
Zou, Cuicui [1 ]
Zou, Shuhui [1 ]
Wang, Qun [2 ]
Xiao, Dejun [1 ]
Zhang, Liqin [1 ]
机构
[1] Ganzhou Peoples Hosp, Ganzhou 341000, Jiangxi, Peoples R China
[2] Luneng Biotechnol Shenzhen Co LTD, Shenzhen 518000, Peoples R China
关键词
Myelodysplastic syndrome; Abnormal hemoglobin H band; ACUTE MYELOID-LEUKEMIA; SIDEROBLASTIC ANEMIA; ALPHA-THALASSEMIA; INACTIVATION; CYTOGENETICS; EXPRESSION; SURVIVAL; CHILDREN; GENE;
D O I
10.1016/j.tracli.2020.10.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Myelodysplastic syndrome (MDS) is a group of heterogeneous diseases derived from hematopoietic stem cells characterized by hemolytic anemia and high risk of conversion to acute leukemia. MDS is an age-related disease in which approximately 80% of patients are over 60years of age, male and female. Anemia is the most common clinical condition, and many patients are also associated with infection and bleeding. When the amount of alpha globin synthesis is insufficient, the remaining beta chain forms tetramer beta 4, i.e. HbH. The latter forms a precipitate in red blood cells, leading to hemolytic anemia, called HbH disease, the majority of which is congenital, a small number of patients with myelodysplastic syndrome and acute myeloid leukemia may appear HbH (called acquired HbH disease). We reported a 71years old male patient diagnosed as myelodysplastic syndromes (MDS) in our hospital. The patient has a negative alpha-thalassemia gene test. The H band is detected by hemoglobin electrophoresis. This article analyzed and discussed this case with MDS, as well reviewed MDS. (C) 2020 Published by Elsevier Masson SAS on behalf of Societe francaise de transfusion sanguine(SFTS).
引用
收藏
页码:206 / 210
页数:5
相关论文
共 50 条
  • [41] Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)
    Bewersdorf, Jan Philipp
    Xie, Zhuoer
    Bejar, Rafael
    Borate, Uma
    Boultwood, Jacqueline
    Brunner, Andrew M.
    Buckstein, Rena
    Carraway, Hetty E.
    Churpek, Jane E.
    Daver, Naval G.
    Della Porta, Matteo Giovanni
    DeZern, Amy E.
    Fenaux, Pierre
    Figueroa, Maria E.
    Gore, Steven D.
    Griffiths, Elizabeth A.
    Halene, Stephanie
    Hasserjian, Robert P.
    Hourigan, Christopher S.
    Kim, Tae Kon
    Komrokji, Rami
    Kuchroo, Vijay K.
    List, Alan F.
    Loghavi, Sanam
    Majeti, Ravindra
    Odenike, Olatoyosi
    Patnaik, Mrinal M.
    Platzbecker, Uwe
    Roboz, Gail J.
    Sallman, David A.
    Santini, Valeria
    Sanz, Guillermo
    Sekeres, Mikkael A.
    Stahl, Maximilian
    Starczynowski, Daniel T.
    Steensma, David P.
    Taylor, Justin
    Abdel-Wahab, Omar
    Xu, Mina L.
    Savona, Michael R.
    Wei, Andrew H.
    Zeidan, Amer M.
    BLOOD REVIEWS, 2023, 60
  • [43] Directed therapy for patients with myelodysplastic syndromes (MDS) by suppression of cyclin D1 with ON 01910.Na
    Olnes, Matthew J.
    Shenoy, Aarthie
    Weinstein, Barbara
    Pfannes, Loretta
    Loeliger, Kelsey
    Tucker, Zachary
    Tian, Xin
    Kwak, Minjung
    Wilhelm, Francois
    Yong, Agnes S. M.
    Maric, Irina
    Maniar, Manoj
    Scheinberg, Phillip
    Groopman, Jerome
    Young, Neal S.
    Sloand, Elaine M.
    LEUKEMIA RESEARCH, 2012, 36 (08) : 982 - 989
  • [44] Dysplasia Has A Differential Diagnosis: Distinguishing Genuine Myelodysplastic Syndromes (MDS) From Mimics, Imitators, Copycats and Impostors
    Steensma, David P.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2012, 7 (04) : 310 - 320
  • [45] Abnormal populations and functions of natural killer cells in patients with myelodysplastic syndromes
    Zhang, Wei
    Xie, Xinyan
    Mi, Huijing
    Sun, Jinwan
    Ding, Shaoxue
    Li, Lijuan
    Liu, Hui
    Wang, Huaquan
    Fu, Rong
    Shao, Zonghong
    ONCOLOGY LETTERS, 2018, 15 (04) : 5497 - 5504
  • [46] Abnormal CD25 expression on hematopoietic cells in myelodysplastic syndromes
    Liu, Pei
    Jiang, Huijuan
    Che, Mengting
    Fu, Rong
    Wang, Huaquan
    Li, Lijuan
    Zhang, Wei
    Tao, Jinglian
    Gao, Shan
    Shao, Zonghong
    LEUKEMIA RESEARCH, 2018, 67 : 12 - 16
  • [47] Peripheral blood MDS score: A new flow cytometric tool for the diagnosis of myelodysplastic syndromes
    Cherian, S
    Moore, J
    Bantly, A
    Vergilio, JA
    Klein, P
    Luger, S
    Bagg, A
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2005, 64B (01) : 9 - 17
  • [48] Myelodysplastic syndrome (MDS) associated with increased hemoglobin F and trisomy 8:: presentation of a patient
    Koç, A
    Öner, R
    Öner, C
    Aktas, D
    Sözen, M
    Tunçbilek, E
    Altay, C
    HEMATOLOGY AND CELL THERAPY, 1999, 41 (04) : 187 - 189
  • [49] Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS)
    Saber, Wael
    Cutler, Corey S.
    Nakamura, Ryotaro
    Zhang, Mei-Jie
    Atallah, Ehab
    Rizzo, J. Douglas
    Maziarz, Richard T.
    Cortes, Jorge
    Kalaycio, Matt E.
    Horowitz, Mary M.
    BLOOD, 2013, 122 (11) : 1974 - 1982
  • [50] Differences in community and academic practice patterns for newly diagnosed myelodysplastic syndromes (MDS) patients
    Pease, Daniel F.
    Ross, Julie A.
    Poynter, Jenny N.
    Nguyen, Phuong L.
    Hirsch, Betsy
    Cioc, Adina
    Roesler, Michelle A.
    Warlick, Erica D.
    CANCER EPIDEMIOLOGY, 2015, 39 (02) : 222 - 228